These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37745452)

  • 21. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the edge: pharmacological evidence for anxiety-related behavior in zebrafish larvae.
    Richendrfer H; Pelkowski SD; Colwill RM; Creton R
    Behav Brain Res; 2012 Mar; 228(1):99-106. PubMed ID: 22155488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establish and use of an epilepsy model in larval zebrafish].
    Zheng YM; Zhang JP; Tang S; Song DQ
    Yao Xue Xue Bao; 2016 Apr; 51(4):580-7. PubMed ID: 29859527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine.
    Kristofco LA; Cruz LC; Haddad SP; Behra ML; Chambliss CK; Brooks BW
    Aquat Toxicol; 2016 Jan; 170():344-354. PubMed ID: 26431593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid reduces the ethanol-induced morphological and behavioral defects in embryonic and larval zebrafish (Danio rerio) as a model for fetal alcohol spectrum disorder (FASD).
    Cadena PG; Cadena MRS; Sarmah S; Marrs JA
    Reprod Toxicol; 2020 Sep; 96():249-257. PubMed ID: 32763456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural Endophenotype Assessment in Zebrafish Larvae Using Optomotor and ZebraBox Locomotion Assessment.
    Xie J; Goodbourn P; Sztal T; Jusuf PR
    Methods Mol Biol; 2024; 2746():213-224. PubMed ID: 38070092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repurposing for Alzheimer's disease:
    Kumar N; Gahlawat A; Kumar RN; Singh YP; Modi G; Garg P
    J Biomol Struct Dyn; 2022 Apr; 40(7):2878-2892. PubMed ID: 33170091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using a variant of the optomotor response as a visual defect detection assay in zebrafish.
    LeFauve MK; Rowe CJ; Crowley-Perry M; Wiegand JL; Shapiro AG; Connaughton VP
    J Biol Methods; 2021; 8(1):e144. PubMed ID: 33604396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Potential Repurposable Drugs in Alzheimer's Disease Exploiting a Bioinformatics Analysis.
    Fiscon G; Sibilio P; Funari A; Conte F; Paci P
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotype-based drug screening: An
    Kumari A; Zeng XA; Rahaman A; Farooq MA; Huang Y; Alee M; Yao R; Ali M; Khalifa I; Badr O
    Front Mol Biosci; 2022; 9():984461. PubMed ID: 36353729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    Norins LC
    J Alzheimers Dis; 2021; 81(3):921-932. PubMed ID: 33843684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract.
    Torres-Hernández BA; Colón LR; Rosa-Falero C; Torrado A; Miscalichi N; Ortíz JG; González-Sepúlveda L; Pérez-Ríos N; Suárez-Pérez E; Bradsher JN; Behra M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2533-47. PubMed ID: 27165438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
    Advani D; Kumar P
    ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    ArXiv; 2023 Oct; ():. PubMed ID: 37961739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for
    Bernatchez JA; Chen E; Hull MV; McNamara CW; McKerrow JH; Siqueira-Neto JL
    Microorganisms; 2020 Mar; 8(4):. PubMed ID: 32224991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA-Approved Drug Screening for Compounds That Facilitate Hematopoietic Stem and Progenitor Cells (HSPCs) Expansion in Zebrafish.
    Feng Z; Lin C; Tu L; Su M; Song C; Liu S; Suryanto ME; Hsiao CD; Li L
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposed agents in the Alzheimer's disease drug development pipeline.
    Bauzon J; Lee G; Cummings J
    Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.